PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 7 results · Patient Organisations · Oncology  · Clear
🔒 Subscribers only
AUTH/3803/07/23
Patient Organisations Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
GSK press release on dostarlimab
An anonymous complainant alleged GSK promoted Jemperli (dostarlimab) via a press release about an MHRA Early Access to Medicines Scheme (EAMS) positive scientific opinion for endometrial cancer.The…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3362/6/20
Patient Organisations Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
Roche voluntarily admitted that a promotional email for Tecentriq (atezolizumab) was inadvertently sent by a third-party agency to members of the public.The email was intended for UK oncologists an…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/2983/10/17
Patient Organisations Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Celgene corporate brochure
An anonymous, non-contactable complainant (appearing to be a clinician) alleged a Celgene booklet, “Life We’re working on it” (ref UK-CELG160202), promoted Abraxane (protein bound paclitaxel)…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2098/2/08
Patient Organisations Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
Following inter-company dialogue (and a complaint from GlaxoSmithKline UK Limited), Roche voluntarily admitted that a one-page piece placed in the 2007 edition of In The Pink magazine promoted pres…
Clauses: 9.1
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/1910/11/06
Patient Organisations Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Sanofi Pasteur MSD v GlaxoSmithKline (AUTH/1910/11/06)
Sanofi Pasteur MSD complained about GlaxoSmithKline’s field-based cervical cancer disease awareness team (CCDAT), alleging its existence and activities breached the Code.Both companies were devel…
Clauses: NONE
2006 🔒 Subscribe
🔒 Subscribers only
AUTH/1918/11/06
Patient Organisations Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Amgen voluntary admission
Amgen made a voluntary admission that Aranesp (darbepoetin alfa), a prescription only medicine, had been promoted to the public.At the National Kidney Foundation (NKF) annual conference (October 20…
Clauses: NONE
2006 🔒 Subscribe
🔒 Subscribers only
AUTH/2257/8/09
Patient Organisations Breach 🏥 Oncology ▶ Video 🎙 Podcast
Ferring — Firmagon (degarelix)
Ferring's PR agency sent an unapproved and misleadingly edited version of a press release about Firmagon to a patient organisation, which then used it to create website content. The edited cop…
Clauses: 2,9.1,14.3,22.2,23.6
2009 🔒 Subscribe
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews